Sign in

Tumori Journal - TJ

@tumorijournal.bsky.social
99 followers 284 following 252 posts

Tumori Journal #TJ is an international peer-reviewed journal that publishes updates in #oncology thanks contributions by opinion leaders and emerging researchers. #OncSky #MedSky journals.sagepub.com/home/TMJ

PostsRepliesMedia
Tumori Journal - TJ @tumorijournal.bsky.social · 04/10/2026
🎙️ #TJTalks #Podcast #CarTCell #Epigenetics #Oncology omny.fm/shows/tumori...
omny.fm
Interdisciplinary Innovations in Epigenetics and CAR-T Cell Therapy - Tumori Journal
Real breakthroughs happen when the research brings together different skills, knowledge and passion. Discover an inspiring perspective on interdisciplinary approaches to CAR-T cell therapies in this…
010
Tumori Journal - TJ @tumorijournal.bsky.social · 02/10/2026
💥 #ProstateCancer A model using simple, routine parameters and PSA doubling time can identify those at minimal risk of reclassification, enabling a safe reduction in #biopsy intensity. 🔓 journals.sagepub.com/doi/10.1177/... #CanSky #OncoSky
000
Tumori Journal - TJ @tumorijournal.bsky.social · 29/09/2026
#Hereditary #cancer genetics is increasingly recognized as an integral component of cancer care🧬 🏥 The authors provide a framework for evaluating and improving diagnostic, care pathways and risk-reduction strategies. 🆓 journals.sagepub.com/share/UUTCPC... #CanSky #OncoSky
011
Tumori Journal - TJ @tumorijournal.bsky.social · 14/09/2026
🆕The Process Mining is a methodological framework for analysing care pathways: it is a powerful approach for analysing and optimising complex workflows. #Radiationtherapy involves multiple steps and resources, making it well suited for PM analysis. journals.sagepub.com/share/CCRTY8... #RadOc
000
Tumori Journal - TJ @tumorijournal.bsky.social · 11/09/2026
Discover an inspiring perspective on interdisciplinary approaches to CAR-T cell therapies in this episode of #TJTalks with Professor Yael David, Head of the laboratory and associate member of the Programme in Chemical Biology at #MSKCancerCenter and Dr Francesca De Santis. omny.fm/shows/tumori...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 09/09/2026
👉Multiparametric Whole-Body Magnetic Resonance Imaging (WB-MRI) may enhance bone metastasis detection in metastatic #breastcancer (mBC) patients. This is what emerges from the preliminary results of a prospective clinical trial in #TJ 🔓 journals.sagepub.com/doi/full/10.... #CanSky #RadOnc
journals.sagepub.com
Sage Journals: Discover world-class research
Subscription and open access journals from Sage, the world's leading independent academic publisher.
000
Tumori Journal - TJ @tumorijournal.bsky.social · 03/09/2026
🆕This study provides an innovative technological framework and preclinical evidence supporting localized mRNA-based #immunotherapy for #bladdercancer. 🔗https://journals.sagepub.com/share/5YFXQYE3FJZFSKNMTDFT?target=10.1177/03008916261463130 #genitourinarycancer #CanSky #OncoSky
000
Tumori Journal - TJ @tumorijournal.bsky.social · 31/08/2026
🌞🌜Circadian and circannual rhythms act as silent determinants of cancer prognosis, influencing interaction between host’s immune system and tumour behaviour. Beyond the calendar: A narrative review on chronobiological drivers of prognosis in resectable NSCLC journals.sagepub.com/share/RBRQST...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 30/08/2026
🎯 What topic do you think might be of interest would you like to take the lead with your guest expert? 👩‍💻Submit your idea for a TJ Talks tumorijournal.org/contact-us/ 🎙️Your proposal if accepted, we will move on to the podcast recording phase. Discover all TJ Talks 🎧 tumorijournal.org/podcast/
000
Tumori Journal - TJ @tumorijournal.bsky.social · 19/08/2026
🎯 What topic do you think might be of interest would you like to take the lead with your guest expert? 👩‍💻Submit your idea for a TJ Talks tumorijournal.org/contact-us/ 🎙️Your proposal if accepted, we will move on to the podcast recording phase. Discover all TJ Talks 🎧 tumorijournal.org/podcast/
000
Tumori Journal - TJ @tumorijournal.bsky.social · 10/08/2026
🎯 What topic do you think might be of interest would you like to take the lead with your guest expert? 👩‍💻Submit your idea for a TJ Talks tumorijournal.org/contact-us/ 🎙️Your proposal if accepted, we will move on to the podcast recording phase. Discover all TJ Talks 🎧 tumorijournal.org/podcast/
000
Tumori Journal - TJ @tumorijournal.bsky.social · 03/08/2026
🆕Does exist statistically significant difference between cisplatin- and carboplatin-based CT-IT in #lungcancer❓ Learn more on this systematic review providing separate outcome data for #carboplatin and #cisplatin. 🔗 journals.sagepub.com/share/55FYJI... #canSky #OncoSky
000
Tumori Journal - TJ @tumorijournal.bsky.social · 31/07/2026
bsky.app/profile/did:...
bsky.app
Tumori Journal - TJ (@tumorijournal.bsky.social)
☢️ #AI development in the carbon ion #radiotherapy domain is in early stages but holds promise for reducing costs and improving treatment. 🎯This review aims to examine current landscape of AI in…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 30/07/2026
🎙️TJ Talks podcasts are also available on Vumedi - the U.S. platform for medical videos and podcasts built exclusively for its 40,000+ oncologist members. ✍️ 💥Submit your idea for a new TJ Talks tumorijournal.org/contact-us/ All the TJ Talks podcasts ➡️ tumorijournal.org Vumedi ➡️ vumedi.com
000
Tumori Journal - TJ @tumorijournal.bsky.social · 29/07/2026
🎙️#TJTalks | Looking forward to the future... Dr. Francesco Pignatti, Scientific advisor for Oncology in the Human Medicine Division of the European Medicines Agency, is the guest of this TJ Talks episode – led by dr. Luca Moscetti.
omny.fm
The role of real-world trials and single-arm trials in the drug approval process - Tumori Journal
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 28/07/2026
#AI | This study aimed to introduce the best artificial intelligence techniques developed for the detection and diagnosis of #breastcancer using microscopic images by fuzzy AHP-TOPSIS techniques 🔗https://t.co/kgmkhfZquF
001
Tumori Journal - TJ @tumorijournal.bsky.social · 27/07/2026
🔬🩸#Liquidbiopsy | The study’s findings support the analytical validity and clinical utility of TruSight Oncology 500 ctDNA, demonstrating high concordance with the FDA-approved Guardant360 CDx in detecting actionable alterations in NSCLC patients progressing on targeted therapies. t.co/X3JZCo5ka5
000
Tumori Journal - TJ @tumorijournal.bsky.social · 26/07/2026
🎙️#TJTalks The #BENCHISTA project aims to better understand the reasons behind international differences in paediatric cancer survival. Prof. Pritchard-Jones explains how the #BENCHISTA data could contribute to further improvements in survival outcomes for children with cancer. t.co/iE9MIsUQl6
000
Tumori Journal - TJ @tumorijournal.bsky.social · 25/07/2026
#AdverseEvent 💥 Alectinib is used in first-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be well tolerated. #Gastrointestinal (#GI) perforation is an extremely rare but potentially life-threatening complication. 🔗 journals.sagepub.com/doi/full/10.... #CanSky #OncoSky
journals.sagepub.com
Alectinib and gastrointestinal perforation in ALK-rearranged non-small cell lung cancer: A case series - Margherita Piccinelli, Raffaele Squitieri, Rebecca Romanò, Silvia Marchesi, Giulia Montelatici, Camilla Damonte, Marta Brambilla, Teresa Beninato, Laura Mazzeo, Giulia Corrao, Marco Meazza Prina, Arsela Prelaj, Claudia Proto, Margherita Galassi, Filippo Guglielmo Maria De Braud, Giuseppe Lo Russo, Mario Occhipinti, Paolo Ambrosini, 2026
Background: Alectinib, a second-generation ALK inhibitor, is used in first-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be both effec...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 24/07/2026
💥#Sarcoma Awareness Month #CanSky To help clarify #palliative care needs, authors investigated discrepancies in end-of-life management b/w Pts with #sarcoma and those with common carcinomas, suggesting that patients with sarcoma may pose special challenges to end-of-life care. t.co/GPJ8W9VG9e
000
Tumori Journal - TJ @tumorijournal.bsky.social · 23/07/2026
💥 Is it possible to rethink monitoring as a considered clinical decision, rather than as an automatic procedure❓ The authors contend that shifting toward evidence-based follow-up is a strategic move designed to reduce unnecessary interventions🏥 🔗 journals.sagepub.com/doi/epub/10.... #CanSky
000
Tumori Journal - TJ @tumorijournal.bsky.social · 20/07/2026
#CanSky #EndOfLife #SupportiveCare #PalliativeCare #hospice #QualityOfLife 🎯 Allowing access to hospice services for selected patients receiving disease-modifying therapies may facilitate better symptom control and improve quality of life near the end of life. journals.sagepub.com/doi/epub/10....
000
Tumori Journal - TJ @tumorijournal.bsky.social · 17/07/2026
bsky.app/profile/tumo...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 17/07/2026
#CanSKy | Alectinib, a second-generation ALK inhibitor, is used in 1°-line and adjuvant treatment for ALK-rearranged NSCLC, and has proven to be well tolerated. #Gastrointestinal perforation is an extremely rare but potentially life-threatening complication. journals.sagepub.com/doi/full/10....
000
Tumori Journal - TJ @tumorijournal.bsky.social · 15/07/2026
#PsyOnc |This study analyzed the role of physical symptoms, illness awareness, individual activities and social contexts on anxious/depressive symptoms and mental health in localized (LP) and advanced/metastatic (AMP) cancer patients. 🔗 journals.sagepub.com/doi/full/10....
010
Tumori Journal - TJ @tumorijournal.bsky.social · 12/07/2026
#TJTalks | Precision oncology is a broad concept based on the study of the #genome of tumour cells, in this podcast Prof. Paolo Marchetti is interviewed by Prof. Giancarlo Pruneri. 🎙️ omny.fm/shows/tumori... #CanSky #OncoSky
omny.fm
Precision Oncology: Multidisciplinary Approach and Artificial Intelligence for Personalized Therapies - Tumori Journal
In this episode of TJ Talks, the guest is Professor Paolo Marchetti, a well-known expert in precision oncology in Italy, Full Professor of Medical Oncology at the University of Rome "La Sapienza",…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 10/07/2026
💥 Is it possible to rethink monitoring as a considered clinical decision, rather than as an automatic procedure? The authors contend that shifting toward personalized, evidence-based follow-up is a strategic move designed to reduce unnecessary interventions🏥 journals.sagepub.com/doi/full/10....
000
Tumori Journal - TJ @tumorijournal.bsky.social · 09/07/2026
🎙️🆕 #BENCHISTA project aims to better understand the reasons behind international differences in paediatric cancer survival. Prof. Kathy Pritchard-Jones explains how the use of its data could contribute to further improvements in survival outcomes. @ucl.ac.uk omny.fm/shows/tumori...
omny.fm
Early Diagnosis as a Determinant of Childhood Cancer Survival: Insights from the BENCHISTA Project - Tumori Journal
The BENCHISTA – International  Benchmarking of Childhood Cancer Survival by Tumor stage – project is a worldwide collaboration led by University College London (UCL)  and Fondazione IRCCS Istituto…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 07/07/2026
🎙️Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by EMA is very important, especially in the context of personalized medicine. 🎧 omny.fm/shows/tumori... #CanSky #OncoSky
omny.fm
The role of real-world trials and single-arm trials in the drug approval process - Tumori Journal
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 06/07/2026
☢️ #AI development in the carbon ion #radiotherapy domain is in early stages but holds promise for reducing costs and improving treatment. 🎯This review aims to examine current landscape of AI in #CIRT and highlight future directions. journals.sagepub.com/doi/full/10.... #RadOnc #radiationoncology
000
Tumori Journal - TJ @tumorijournal.bsky.social · 05/07/2026
🎙️ #TJTlaks Podcast omny.fm/shows/tumori...
omny.fm
The role of real-world trials and single-arm trials in the drug approval process - Tumori Journal
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 02/07/2026
Dr. Giovanni Leuzzi discusses #chronobiology as potential new dimension of precision medicine. 🕛 ☀️ 🍂 Biological processes such as immune responses, inflammation, and DNA repair follow daily and seasonal rhythms regulated by the body’s biological clock. youtu.be/A5oaCkUwxdw?... #LungCancer #LCSM
youtu.be
Chronobiology and inflammation in early-stage NSCLC: Beyond the Anatomical Paradigm
YouTube video by Tumori Journal
000
Tumori Journal - TJ @tumorijournal.bsky.social · 02/07/2026
🕐☀️🍂Biological processes such as immune responses, inflammation, and DNA repair follow daily and seasonal rhythms regulated by the body’s biological clock. I 📽️Dr. Giovanni Leuzzi (Thoracic Surgeon) discusses #chronobiology as a potential new dimension of #precisionmedicine. ⏯️ youtu.be/A5oaCkUwxdw
youtu.be
Chronobiology and inflammation in early-stage NSCLC: Beyond the Anatomical Paradigm
Dr. Giovanni Leuzzi (Thoracic Surgeon, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy) discusses chronobiology as a potential new dimension of precision medicine. Biological processes…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 30/06/2026
💥#MeetTheEditors is dedicated to the #PrecisionOncology section, which publishes cutting-edge research on mutations, prognostic factors, personalized biomarkers, and non-invasive diagnostics in cancer. Discover its renowned Editors👇 tumorijournal.org/about-us/#ed...
100
Tumori Journal - TJ @tumorijournal.bsky.social · 26/06/2026
👀Find out how #liquidbiopsy is absolutely the new goal of #precisiononcology in this TJ Talks with Prof. Andrea Sartore Bianchi – Director of the Division of Clinical Research and Innovation in Medical Oncology at the Grande Ospedale Metropolitano Niguarda in Milan. 🎙️
omny.fm
Liquid biopsy and molecularly driven therapies for colorectal cancer: current and future applications in precision oncology - Tumori Journal
If we were to stop at a first glance, the use of liquid biopsy would be limited in the clinical practice of colorectal cancer to cases where tumour tissue is unavailable or insufficient. In reality,…
000
Tumori Journal - TJ @tumorijournal.bsky.social · 25/06/2026
🔬🩸Findings support the analytical validity and clinical utility of TruSight Oncology 500 ctDNA, demonstrating high concordance with the FDA-approved Guardant360 CDx (G360) in detecting actionable alterations in NSCLC pts. journals.sagepub.com/doi/10.1177/... #LungCancer #CanSky #PathSky
000
Tumori Journal - TJ @tumorijournal.bsky.social · 23/06/2026
🎙️ #TJTalks | Prof. Giancarlo Pruneri and Dr. Emanuele Frigo on the role of pathologists in precision medicine: PhD in #Pathology omny.fm/shows/tumori... #CanSky #OncoSky #PathSky
omny.fm
PhD in Pathology: Prof. Giancarlo Pruneri and Dr. Emanuele Frigo on the role of pathologists in precision medicine - Tumori Journal
The role of pathologists in precision oncology is increasingly recognised as central to effective cancer diagnosis and treatment. Their expertise in tumor classification and biomarker identification i...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 22/06/2026
💥 #PalliativeCare: authors investigated discrepancies in #EndofLife management between patients with #sarcoma and those with the most common #carcinomas, suggesting that patients with sarcoma may pose special challenges to end-of-life care. 🔗 journals.sagepub.com/doi/10.1177/... #Cansky #OncoSky
000
Tumori Journal - TJ @tumorijournal.bsky.social · 15/06/2026
🐁🐁🐁 The current models, their strengths and weaknesses, and suggests better solutions using multi-#omics data, #AI model, standard protocols: 👇 learn more at the link journals.sagepub.com/share/DXRUFJ...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 13/06/2026
💥 Authors report a single-center experience of HN Ewing #sarcoma among #pediatric patients, over a period of 20 years, with the intent of increasing knowledge and reporting their experience on multimodal management of this peculiar localization. journals.sagepub.com/doi/10.1177/...
010
Tumori Journal - TJ @tumorijournal.bsky.social · 12/06/2026
#gyncsm #CanSky What emerges from the most recent first-line trials is that progress in advanced #ovariancancer depends not only on new treatment, but on better patient selection. Appropriate treatment must be determined for each individual: best treatment for each patient omny.fm/shows/tumori...
010
Tumori Journal - TJ @tumorijournal.bsky.social · 11/06/2026
💥What happens when #prostatecancer locally recurs after two previous courses of #radiationtherapy⁉️ This retrospective analysis explores feasibility, safety profile and oncological outcomes of a third RT course in this clinical scenario💊 journals.sagepub.com/doi/full/10.... #CanSKY #OncoSky #pcsm
000
Tumori Journal - TJ @tumorijournal.bsky.social · 09/06/2026
#PsyOnc | This study analyzed the role of physical symptoms, illness awareness, individual activities and social contexts on anxious/depressive symptoms and mental health in localized (LP) and advanced/metastatic (AMP) cancer patients. 🔗 journals.sagepub.com/doi/full/10.... #cansky #oncosky
000
Tumori Journal - TJ @tumorijournal.bsky.social · 08/06/2026
💥Natural killer/T-cell lymphoma (NKTCL) is an aggressive #lymphoma In their *Diagnostic and prognostic role of GPX1 in NK/T cell lymphoma*, Authors identified a link between varying expression levels of GPX1 and the onset, diagnosis, and prognosis of NKTCL. journals.sagepub.com/share/GFZ9CR...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 08/06/2026
Children asked not only what the tumor was and how it was treated, but also why it happened, why to them, and how others perceived them The “empty speech bubbles”: Explaining cancer through play. A pediatric oncology unit pilot experience 👉 journals.sagepub.com/share/3GRWX2...
000
Tumori Journal - TJ @tumorijournal.bsky.social · 05/06/2026
🥁Tumori Journal embraces #TransparentPeerReview. ✍️Authors can now opt-in to have the peer review reports associated with their manuscripts published alongside the final article. Join the oncology community in shaping the debate, submit to #TumoriJournal journals.sagepub.com/author-instr...
291
Reposted by Tumori Journal - TJ
Tumori Journal - TJ @tumorijournal.bsky.social · 28/05/2026
#gyncsm #CanSky What emerges from the most recent first-line trials is that progress in advanced #ovariancancer depends not only on new treatment, but on better patient selection. Appropriate treatment must be determined for each individual: best treatment for each patient omny.fm/shows/tumori...
001
Tumori Journal - TJ @tumorijournal.bsky.social · 29/05/2026
💥 Authors report a single-center experience of HN Ewing #sarcoma among #pediatric patients, over a period of 20 years, with the intent of increasing knowledge and reporting their experience on multimodal management of this peculiar localization. journals.sagepub.com/doi/10.1177/...
010
Tumori Journal - TJ @tumorijournal.bsky.social · 28/05/2026
#gyncsm #CanSky What emerges from the most recent first-line trials is that progress in advanced #ovariancancer depends not only on new treatment, but on better patient selection. Appropriate treatment must be determined for each individual: best treatment for each patient omny.fm/shows/tumori...
001
Tumori Journal - TJ @tumorijournal.bsky.social · 27/05/2026
There is a growing need to develop non-invasive strategies that can support imaging techniques in early detection of #breastcancer identification of novel diagnostic markers by including metabolites, in blood or other non-invasive fluids such exhaled breath journals.sagepub.com/doi/full/10....
000